Search Results for "New Biomarkers and Prognostic Indicators in Leukemia and MDS"

New Biomarkers and Prognostic Indicators in Leukemia and MDS

Molecular Biomarkers Predictive for Response to Immunosuppressive Therapy in MDS

Classification and Prognosis in MDS

Novel strategies to evaluate biomarkers of interest in multiple myeloma

Why MPN transforms to AML

What Is a CLL Biomarker?

Higher-risk MDS and newly diagnosed AML: What are the latest developments from EHA 2022?

Diagnostic and Prognostic Biomarkers

Predicting Prognosis in Myelodysplastic Syndromes

New approaches to treat myeloid neoplasms

Integrated sequencing in AML/MDS reveals prognostic constellations

MDS: The Current Understanding in Molecular Testing and Biomarkers